Scott Parker

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Immune Response

Tyrosine Kinase

Top Venues

Science translational medicine

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Franziska Gsottberger, Christina Meier, Anna Ammon, Scott Parker, Kerstin Wendland, Rebekka George, Srdjan Petkovic, Lisa Mellenthin, Charlotte Emmerich, Gloria Lutzny-Geier, Markus Metzler, Andreas Mackensen, Vidyalakshmi Chandramohan, Fabian Müller
Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response. Cell death & disease 14 (8) (2023)
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, Cristina Osorio, Patrick C Duncker, Aaron Briley, Adam M Swartz, James E Herndon, Yen-Rei A Yu, Roger E McLendon, Thomas F Tedder, Annick Desjardins, David M Ashley, Michael Dee Gunn, David S Enterline, David A Knorr, Ira H Pastan, Smita K Nair, Darell D Bigner, Vidyalakshmi Chandramohan
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science translational medicine 15 (682) (2023)
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, Cristina Osorio, Patrick C Duncker, Aaron Briley, Adam M Swartz, James E Herndon, Yen-Rei A Yu, Roger E McLendon, Thomas F Tedder, Annick Desjardins, David M Ashley, Michael Dee Gunn, David S Enterline, David A Knorr, Ira H Pastan, Smita K Nair, Darell D Bigner, Vidyalakshmi Chandramohan
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science translational medicine 15 (682) (2023)
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, Cristina Osorio, Patrick C Duncker, Aaron Briley, Adam M Swartz, James E Herndon, Yen-Rei A Yu, Roger E McLendon, Thomas F Tedder, Annick Desjardins, David M Ashley, Michael Dee Gunn, David S Enterline, David A Knorr, Ira H Pastan, Smita K Nair, Darell D Bigner, Vidyalakshmi Chandramohan
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science translational medicine 15 (682) (2023)